← Open Payments lookup

D'LAYNA BRENING: Open Payments

NPI 1043672561 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$177 in 9 payments from 8 companies in 2025. Trend: 2023 $105 · 2024 $0 · 2025 $177

Food & beverage: $177
CompanyPaymentsAmount
Novo Nordisk Inc2$36
Takeda Pharmaceuticals U.S.A., Inc.1$29
Otsuka America Pharmaceutical, Inc.1$28
Lundbeck LLC1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Esperion Therapeutics, Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14
Phathom Pharmaceuticals, Inc.1$14

Products named: REXULTI, TRINTELLIX, Rybelsus, CAPLYTA, NEXLETOL, XIFAXAN, VOQUEZNA.

Industry payments across NE — which companies pay providers there.